Keyword "AGGREGATION" found in the following publications:

• IN-SILICO INSIGHTS INTO Α-SYNUCLEIN MEDIATED PATHOLOGY OF PARKINSON’S DISEASE USING MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATION STUDIES
   

  Background: The precise cause of neuronal loss in Parkinson's disease (PD) is multifactorial, involving genetic and environmental factors. ...

  Abstract | Full text (PDF)

• PATHOLOGICAL CONDITIONS ASSOCIATED WITH TAU PROTEIN: MECHANISMS OF DEVELOPMENT AND POSSIBLE BIOLOGICAL TARGETS FOR PHARMACOLOGICAL CORRECTION OF TAU PROTEINOPATHY (REVIEW)

  Background: The pathological process associated with the pathogenic aggregation of tau is called taupathy. The same term is often ...

  Abstract | Full text (PDF)

• L-NAME-INDUCED PREECLAMPSIA: CORRECTION OF FUNCTIONAL DISORDERS OF THE HEMOSTASIS SYSTEM WITH RESVERATROL AND NICORANDIL

  Introduction. Preeclampsia is a formidable disease of the second half of pregnancy, leading to severe complications, including disability and even death. ...

  Abstract | Full text (PDF)

• PLEYOTROPIC ANTIAGGREGANT EFFECTS OF AN INNOVATIVE ANTIARRHYTHMIC OF CLASS III SS-68, AN INDOLE DERIVATIVE

  Background: A new indole derivative with the lab code-number SS-68 demonstrates a significant antiarrhythmic (anti-fibrillation) activity associated with the ...

  Abstract | Full text (PDF)

• THE STATE OF MICROCIRCULATION IN PREGNANT WOMEN WITH HYPERTENSIVE DISORDERS IN THE THIRD TRIMESTER OF PREGNANCY
   

  Background: Hypertensive disorders during pregnancy remain the most significant problem of modern obstetrics, taking the main place in the ...

  Abstract | Full text (PDF)

• EVALUATION OF PHARMACOLOGICAL CORRECTION OF L-NAME-INDUCED ENDOTHELIAL DYSFUNCTION, PLATELET AGGREGATION AND VENOUS TONE WITH DIOSMIN DETRALEX 1000 MG

  Introduction. Chronic venous diseases are one of the urgent problems of modern medicine. Recent studies have shown high significance of endothelial ...

  Abstract | Full text (PDF)